Related Experiment Video
Updated: May 26, 2025

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
Design and implementation of a risk-adapted, longitudinal, theory-driven medication adherence intervention: A
Benyam Muluneh1, Maurlia Upchurch2, Bethel Belayneh3
1Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, USA.
This study develops a medication adherence intervention for oral anticancer agents (OAAs) to improve patient outcomes. The risk-adapted, longitudinal approach aims for scalable and sustainable support in routine cancer care.
Area of Science:
- Oncology
- Implementation Science
- Behavioral Science
Background:
- Oral anticancer agents (OAAs) have transformed cancer care, but suboptimal patient adherence is a significant challenge in real-world settings.
- Developing effective strategies to improve adherence to OAAs is crucial for maximizing treatment efficacy and patient outcomes.
Purpose of the Study:
- To design, implement, and evaluate a multi-phasic, hybrid effectiveness-implementation trial for a risk-adapted, longitudinal medication adherence intervention.
- To address cognitive, behavioral, and environmental barriers impacting patient adherence to OAAs.
Main Methods:
- The study employs social cognitive theory, intervention mapping, and implementation science principles.
- Phase 1 involves identifying barriers and refining strategies through expert input and interviews.
- Phase 2 focuses on patient-centered feedback to tailor the intervention, followed by a pilot in Phase 3 to assess effectiveness and feasibility.
Main Results:
- This section is not applicable as the abstract describes a study protocol and not results.
- The protocol outlines a phased approach to intervention development and evaluation.
Conclusions:
- The trial aims to establish a scalable and sustainable model for medication adherence support in cancer care.
- Successful implementation has broad implications for enhancing patient outcomes and integrating adherence monitoring into routine clinical practice.
More Related Videos
Related Concept Videos
Drug Therapy
Antianxiety Medications
Longitudinal Studies
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Longitudinal Research
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

